These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
13. Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals. Govan B; Ketheesan N Clin Microbiol Infect; 2004 Jun; 10(6):585-7. PubMed ID: 15191392 [TBL] [Abstract][Full Text] [Related]
14. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis. Swetha RG; Sandhya M; Ramaiah S; Anbarasu A J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038 [TBL] [Abstract][Full Text] [Related]
15. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Barnes JL; Ketheesan N Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei. Tippayawat P; Saenwongsa W; Mahawantung J; Suwannasaen D; Chetchotisakd P; Limmathurotsakul D; Peacock SJ; Felgner PL; Atkins HS; Titball RW; Bancroft GJ; Lertmemongkolchai G PLoS Negl Trop Dis; 2009; 3(4):e407. PubMed ID: 19352426 [TBL] [Abstract][Full Text] [Related]
17. Immune response to Burkholderia pseudomallei. Panomket P J Med Assoc Thai; 2011 Nov; 94(11):1410-7. PubMed ID: 22256484 [TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Barnes JL; Warner J; Melrose W; Durrheim D; Speare R; Reeder JC; Ketheesan N Clin Immunol; 2004 Oct; 113(1):22-8. PubMed ID: 15380526 [TBL] [Abstract][Full Text] [Related]
19. Development of Burkholderia mallei and pseudomallei vaccines. Silva EB; Dow SW Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691 [TBL] [Abstract][Full Text] [Related]
20. Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei. Chin CY; Monack DM; Nathan S Immunology; 2012 Apr; 135(4):312-32. PubMed ID: 22136109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]